17436580

Source:http://linkedlifedata.com/resource/pubmed/id/17436580

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists.
Subject	Predicate	Object	Context
pubmed-article:17436580	rdf:type	pubmed:Citation	lld:pubmed
pubmed-article:17436580	lifeskim:mentions	umls-concept:C0086418	lld:lifeskim
pubmed-article:17436580	lifeskim:mentions	umls-concept:C0225336	lld:lifeskim
pubmed-article:17436580	lifeskim:mentions	umls-concept:C0041637	lld:lifeskim
pubmed-article:17436580	lifeskim:mentions	umls-concept:C0178551	lld:lifeskim
pubmed-article:17436580	lifeskim:mentions	umls-concept:C0596087	lld:lifeskim
pubmed-article:17436580	lifeskim:mentions	umls-concept:C0441655	lld:lifeskim
pubmed-article:17436580	lifeskim:mentions	umls-concept:C1328702	lld:lifeskim
pubmed-article:17436580	lifeskim:mentions	umls-concept:C0538648	lld:lifeskim
pubmed-article:17436580	pubmed:issue	2	lld:pubmed
pubmed-article:17436580	pubmed:dateCreated	2007-4-17	lld:pubmed
pubmed-article:17436580	pubmed:abstractText	TZT-1027 (Soblidotin), a microtubule-depolymerizing agent, has antivascular activity which disrupts newly formed tumor vasculature. In this study, it was investigated whether TZT-1027 has also antiangiogenic activity preventing neovascularization.	lld:pubmed
pubmed-article:17436580	pubmed:language	eng	lld:pubmed
pubmed-article:17436580	pubmed:journal	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:17436580	pubmed:citationSubset	IM	lld:pubmed
pubmed-article:17436580	pubmed:chemical	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:17436580	pubmed:chemical	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:17436580	pubmed:chemical	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:17436580	pubmed:chemical	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:17436580	pubmed:chemical	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:17436580	pubmed:chemical	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:17436580	pubmed:status	MEDLINE	lld:pubmed
pubmed-article:17436580	pubmed:issn	0258-851X	lld:pubmed
pubmed-article:17436580	pubmed:author	pubmed-author:EndoYoshioY	lld:pubmed
pubmed-article:17436580	pubmed:author	pubmed-author:WatanabeJunic...	lld:pubmed
pubmed-article:17436580	pubmed:author	pubmed-author:NatsumeTsugit...	lld:pubmed
pubmed-article:17436580	pubmed:author	pubmed-author:KobayashiMoto...	lld:pubmed
pubmed-article:17436580	pubmed:author	pubmed-author:SasakiTakumaT	lld:pubmed
pubmed-article:17436580	pubmed:author	pubmed-author:ShimadaNamiN	lld:pubmed
pubmed-article:17436580	pubmed:issnType	Print	lld:pubmed
pubmed-article:17436580	pubmed:volume	21	lld:pubmed
pubmed-article:17436580	pubmed:owner	NLM	lld:pubmed
pubmed-article:17436580	pubmed:authorsComplete	Y	lld:pubmed
pubmed-article:17436580	pubmed:pagination	297-304	lld:pubmed
pubmed-article:17436580	pubmed:dateRevised	2008-11-21	lld:pubmed
pubmed-article:17436580	pubmed:meshHeading	pubmed-meshheading:17436580...	lld:pubmed
pubmed-article:17436580	pubmed:meshHeading	pubmed-meshheading:17436580...	lld:pubmed
pubmed-article:17436580	pubmed:meshHeading	pubmed-meshheading:17436580...	lld:pubmed
pubmed-article:17436580	pubmed:meshHeading	pubmed-meshheading:17436580...	lld:pubmed
pubmed-article:17436580	pubmed:meshHeading	pubmed-meshheading:17436580...	lld:pubmed
pubmed-article:17436580	pubmed:meshHeading	pubmed-meshheading:17436580...	lld:pubmed
pubmed-article:17436580	pubmed:meshHeading	pubmed-meshheading:17436580...	lld:pubmed
pubmed-article:17436580	pubmed:meshHeading	pubmed-meshheading:17436580...	lld:pubmed
pubmed-article:17436580	pubmed:meshHeading	pubmed-meshheading:17436580...	lld:pubmed
pubmed-article:17436580	pubmed:meshHeading	pubmed-meshheading:17436580...	lld:pubmed
pubmed-article:17436580	pubmed:meshHeading	pubmed-meshheading:17436580...	lld:pubmed
pubmed-article:17436580	pubmed:meshHeading	pubmed-meshheading:17436580...	lld:pubmed
pubmed-article:17436580	pubmed:meshHeading	pubmed-meshheading:17436580...	lld:pubmed
pubmed-article:17436580	pubmed:articleTitle	Antiangiogenic activity of TZT-1027 (soblidotin) on chick chorioallantoic membrane and human umbilical vein endothelial cells.	lld:pubmed
pubmed-article:17436580	pubmed:affiliation	ASKA Pharmaceutical Co., Ltd., Research and Development Division, 1604 Shimosakunobe, Takatsu-ku, Kawasaki-shi, Kanagawa 213-8522, Japan. watanabe-j@askapharma.co.jp	lld:pubmed
pubmed-article:17436580	pubmed:publicationType	Journal Article	lld:pubmed